Botulinum Toxin Treatment  (e-bog) af Jabbari, Bahman
Jabbari, Bahman (forfatter)

Botulinum Toxin Treatment e-bog

436,85 DKK (inkl. moms 546,06 DKK)
Very few therapeutic agents in clinical medicine have found indication for so many clinical conditions, and in such a short time as did botulinum neurotoxins (Botox and others).  Chronic migraine, bladder dysfunction , dystonia, hemifacial spasm , blepharospasm , drooling, excessive sweating and  spasticity are all approved by FDA  and many other indications are in the near horiz...
E-bog 436,85 DKK
Forfattere Jabbari, Bahman (forfatter)
Forlag Springer
Udgivet 13 november 2018
Genrer Medicine: general issues
Sprog English
Format epub
Beskyttelse LCP
ISBN 9783319999456
Very few therapeutic agents in clinical medicine have found indication for so many clinical conditions, and in such a short time as did botulinum neurotoxins (Botox and others).  Chronic migraine, bladder dysfunction , dystonia, hemifacial spasm , blepharospasm , drooling, excessive sweating and  spasticity are all approved by FDA  and many other indications are in the near horizon .  The aesthetic/cosmetic use of Botox and other BoNTs already has a huge market worldwide. Stroke, Multiple sclerosis, Parkinson's disease, Cerebral palsy as well as brain and  spinal injury are among clinical conditions in which some of  patients' major symptoms can respond to botulinum toxin therapy  Several books have been written on the subject of Botox and other neurotoxins for treatment of  medical disorders ( including two books by Jabbari both published by Springer 2015 & 2017).  However, despite the huge interest and enthusiasm of the public to learn more about Botox and other toxins, there is currently no book in the market on this subject which is specifically designed to inform and educate the public on botulinum toxin therapy. Botulinum Toxin Treatment explains and discusses in simple language the structure and function of botulinum toxin and other neurotoxins as well as the rational for its utility in different disease conditions. Safety, factors affecting efficacy and duration of action, as well as cost and insurance issues are also addressed.